Litcius/Paper detail

Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer

Lei Xue, Fengju Chen, Fei Yue, Laura Camacho, Sushma Kothapalli, Guanyun Wei, Shixia Huang, Qianxing Mo, Fei Ma, Yi Li, Sao Jiralerspong

2020Breast Cancer Research and Treatment29 citationsDOIOpen Access PDF

Topics & Concepts

MetforminTriple-negative breast cancerInsulin receptorPharmacologyMedicineBreast cancerCell growthCancer researchInsulinCancerInternal medicineEndocrinologyBiologyInsulin resistanceBiochemistryMetabolism, Diabetes, and CancerGrowth Hormone and Insulin-like Growth FactorsCancer Risks and Factors
Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer | Litcius